Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORE-001 in Preventing Postoperative Gastrointestinal Disturbance
NCT05923086Phase 2Recruiting
- Sponsor
- Orexa
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in postoperative ileus (POI), sponsored by Orexa. Started Jan 2024; status: recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05923086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923086.